Related Experiment Video
Updated: May 14, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children
Jeremie H Estepp1, Matthew P Smeltzer, Winfred C Wang
1Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA. jeremie.estepp@stjude.org
Insights
Elevated fetal hemoglobin (HbF) protects against sickle cell retinopathy in children. Lower HbF levels significantly increase retinopathy risk, suggesting hydroxycarbamide therapy may prevent this complication.
Area of Science:
- Hematology
- Ophthalmology
- Pediatrics
Background:
- Sickle cell anemia (HbSS) is a genetic blood disorder with various complications.
- Elevated fetal hemoglobin (HbF) is known to ameliorate some sickle cell disease manifestations.
- The effect of HbF on sickle cell retinopathy remains unclear.
Purpose of the Study:
- To investigate the association between fetal hemoglobin levels and the development of retinopathy in children with sickle cell anemia.
- To determine if elevated HbF has a protective effect against retinopathy in this population.
Main Methods:
- Retrospective analysis of 123 children with HbSS.
- Assessment of retinopathy prevalence and correlation with HbF levels.
- Evaluation of HbF levels in children treated with hydroxycarbamide.
Main Results:
- 10.6% of children with HbSS developed retinopathy.
- Children with HbF <15% had a 7.1-fold higher odds of developing retinopathy, independent of hydroxycarbamide treatment.
- In hydroxycarbamide-treated children, those with retinopathy had significantly lower HbF levels (9% vs. 16%, P = 0.005).
Conclusions:
- Elevated fetal hemoglobin (HbF) demonstrates a protective effect against retinopathy in children with sickle cell anemia (HbSS).
- Data suggests that hydroxycarbamide therapy, by inducing HbF, may serve as a preventative strategy for retinopathy in these children.
Abstract:
Elevated foetal haemoglobin (HbF) levels are protective against some manifestations of sickle cell anaemia but the impact on retinopathy is unknown. We report on 123 children with HbSS, 10.6% of whom developed retinopathy. Independent of hydroxycarbamide, children with a HbF <15% had 7.1-fold (95% confidence interval, 1.5-33.6) higher odds of developing retinopathy. In children treated with hydroxycarbamide, those with retinopathy had lower HbF levels compared to children without retinopathy (9% vs. 16%; P = 0.005). We report a protective benefit of elevated HbF regarding retinopathy, and our data suggests induction of HbF with hydroxycarbamide may prevent retinopathy in children.
More Related Videos
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Diabetic Retinopathy
Multiple Allele Traits
Rh Blood Group
Genetic Lingo
Regulation of Hematopoietic Stem Cells
